2 research outputs found

    Experimental investigation on evacuated tube solar collector using biofluid as heat transfer fluid

    Get PDF
    Bio-oil extracted from waste of different plant kernel was used as heat transfer fluid in evacuated tube solar collector. Thermal performance of the biofluids to the enhancement of the evacuated tube solar collector under varying weather conditions and experimental analysis was carried-out. Thermal analysis on the storage water tank temperature, outlet and inlet heat transfer fluid temperature, and heat gains by was studied. In addition, the biofluids thermophysical properties and degradation analysis was conducted and compared with conventional base-fluids. From the results the biofluids caused enhancement of heat gain in the collector receiver by 9.5%, 6.4% and 3.2% for moringa oleifera kernel oil (MOKO), date kernel oil (DKO) and palm kernel oil (PKO), respectively. The storage water tank temperature at night fall was 53, 49, 51 and 47oC, for the MOKO, DKO, PKO and water HTFs, respectively. The biofluids were thermal stable and with no degradation. The biofluids demonstrated potentials as heat transfer fluids in thermal applications but there are needs for more investigations on their enhancement with organically synthesized nano particles to preserve there no corrosive and toxicity nature, and experimental performance on heat exchangers after several heating cycles

    SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

    No full text
    Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population
    corecore